Skip to content

Compliance Toolkit for Approvals, Notifications and Other Regulatory Submissions to MAS under the SFA

Back to MAS Notices

Previous Next


Source

  • Issuer: Monetary Authority of Singapore (MAS)
  • Act: Securities and Futures Act 2001 (SFA)
  • Last revised: 13 November 2025
  • Document type: Compliance Toolkit

Overview

This toolkit provides guidance on applications for approvals, notifications to be submitted, and other regulatory submissions (e.g. financial returns) to MAS under the SFA. It covers common submissions and excludes those imposed bilaterally on specific FIs.

Applicability

(a) CMS Licensees for the following regulated activities:

  • Dealing in capital markets products
  • Advising on corporate finance
  • Product financing
  • Providing custodial services
  • Providing credit rating services

(b) Entities exempted from holding a CMS licence:

  • Exempt CMS entities (banks, merchant banks, finance companies, insurers)
  • Exempt futures brokers
  • Exempt OTC derivatives brokers
  • Exempt corporate finance advisers

Key Legislative Instruments

  1. Securities and Futures Act 2001 (SFA) -- Parts IV, V, IX
  2. Securities and Futures (Licensing and Conduct of Business) Regulations (LCBR)
  3. Securities and Futures (Financial and Margin Requirements for Holders of CMS Licences) Regulations (FMR)
  4. SF(ECBA)(FRC)R -- Cross-Border Arrangements (Foreign Related Corporations) 2021
  5. SF(ECBA)(FO)R -- Cross-Border Arrangements (Foreign Offices) 2021
  6. SFA04-N17 -- Requirements re Cross-Border Arrangements under SF(ECBA)(FRC)R
  7. SFA04-N18 -- Requirements re Cross-Border Arrangements under SF(ECBA)(FO)R
  8. Standard corporate licence conditions on CMS Licensees

Mode of Submission

  • Refer to the relevant form on the MAS website for submission instructions
  • Submissions via FormSG and MAS-Tx: do not encrypt uploaded attachments
  • Financial returns: submit via CoRe (MAS-Tx) or MAS-Tx
  • FIs may log in to MAS-Tx for due dates, email reminders, and copies of submissions

Section A: CMS Licensees

A1: Applications for Approvals from MAS

S/N Requirement Form Deadline Reference
1 Application for CMS licence Form 1 Prior to carrying on regulated activity Section 84(1) SFA
2 Application for additional regulated activities Form 5 Prior to carrying on additional activity Section 90(1) SFA, Reg 11A LCBR
3 Application for additional capital markets products dealing Form 5 Prior to dealing Licence condition
4 Appointment of CEO or director Form 11 Prior to appointment Section 96(1) SFA, Reg 12 LCBR
5 Obtaining effective control of CMS Licensee Application form Prior to obtaining effective control Section 97A(2) SFA
6 Change of shareholders (20%+ control) No prescribed form Prior to change Licence condition
7 Acquire 20%+ interest in corporation / establish branch No prescribed form Prior to acquisition/establishment Licence condition
8 Comply with different base capital requirement No prescribed form Prior to commencing/ceasing/changing business Reg 4(1A) FMR
9 Reduce paid-up share capital No prescribed form Prior to reduction Reg 20 FMR
10 Make unsecured loan / pay dividend / increase director fees under prescribed circumstances No prescribed form Prior to the action Reg 23 FMR
11 Disclose inspection reports to non-auditor No prescribed form Prior to disclosure Sections 150A(2)(c), 150C(2)(d) SFA
12 Disclose investigation reports (MAS investigation) No prescribed form Prior to disclosure Section 152A(2) SFA

A2: Notifications to MAS

S/N Requirement Form Deadline Reference
13 Cessation of business Form 7 (a) Immediately after 6-month period; (b) Within 14 days of cessation Section 93(1) SFA, Reg 11 LCBR
14 Change of name / principal place of business Form 10 Within 14 days from date of change Section 93(1)(b) SFA
15 Material adverse change to financial position (insolvency, inability to meet obligations, suspended payments) No prescribed form Immediate Section 97C(1) SFA
16 Change in shareholders (<20% control) No prescribed form Immediate Licence condition
17 Execution of agreement for purchase/sale/merger of business No prescribed form 7 days prior to execution Licence condition
18 Resignation of CEO / director; change in director appointment nature / residence / business interests No prescribed form Immediate Licence condition
19 Fitness & propriety concerns (officers/reps committed offences, subject to disciplinary action, breach of laws) No prescribed form Immediate Licence condition
20-26 Financial and margin notifications (base capital breach, total risk requirement breach, aggregate indebtedness, preference shares, subordinated loans, under-margined accounts) No prescribed form Immediate Various FMR Regulations
27 Cross-border arrangements commencement Form FN Within 14 days of commencement Regs 4(2), 5(1) SF(ECBA)(FRC)R
28 Changes to cross-border arrangements Form FC Within 14 days from date of change SFA04-N17, SFA04-N18

A3: Regulatory Submissions to MAS

S/N Requirement Form Deadline Submission Mode
29 Statement of assets and liabilities (quarterly and annual) Form 1 Quarterly: 14 days from quarter end; Annual: 5 months from FY end CoRe (MAS-Tx)
30 Financial resources, total risk, aggregate indebtedness (quarterly and annual) Form 2 Same as above CoRe (MAS-Tx)
31 Base capital information (credit rating services) No prescribed form Within 14 days from quarter end MAS-Tx
32 Profit and loss statement Form 3 Within 5 months from FY end CoRe (MAS-Tx)
33 Supplementary financial information Form 4 Within 5 months from FY end CoRe (MAS-Tx)
34 Auditor's report on internal controls Form 5 Within 5 months from FY end MAS-Tx
35 Auditor's certification on financial statements Form 6 Within 5 months from FY end MAS-Tx
36-38 Margin exposures (approved exchanges, customers, margined products) Forms 7-9 Within 14 days from quarter end CoRe (MAS-Tx)
39 Cross-border arrangements annual declaration Form FR Within 5 months from FY end MAS-Tx

Section B: Exempt CMS Entities

Applies to banks, merchant banks, finance companies, and insurers conducting regulated activities under the SFA (exempt from CMS licence under section 99(1)(a), (b), (c) and (d)).

Key requirements include:

  • Approvals: Disclosure of inspection/investigation reports (S/N 40-41)
  • Notifications: Commencement of business (Form 26), change of particulars (Form 27), cessation (Form 29), cross-border arrangements (Forms FN/FC), financial and margin notifications
  • Regulatory submissions: Business unit information (Form 28), cross-border annual declaration (Form FR), compliance confirmation

Section C: Exempt Futures Brokers and Exempt OTC Derivatives Brokers

Key requirements include:

  • Approvals: Disclosure of inspection/investigation reports (S/N 49-50)
  • Notifications: Commencement of business (Form 30), change of particulars (Form 31), cessation (Form 32), breach of licence exemption conditions, cross-border arrangements (Forms FN/FC)
  • Regulatory submissions: Annual compliance declaration (Form 33), auditor's reports (Form 34), profit and loss statement, cross-border annual declaration (Form FR)

Section D: Exempt Corporate Finance Advisers

Key requirements include:

  • Approvals: Disclosure of inspection/investigation reports (S/N 61-62)
  • Notifications: Commencement of business (Form 22), change of particulars (Form 23), cessation (Form 24)
  • Regulatory submissions: Annual compliance declaration (Form 25)

Section E: Representative Notifications (All CMS Licensees and Exempt CMS Entities)

S/N Requirement Form Deadline
67 Appointment of appointed representative Form 3A Prior to appointment
68 Appointment of provisional representative Form 3B Prior to appointment
69 Appointment of temporary representative Form 3C Prior to appointment
70 Completion of examination requirements (provisional rep) Form 3D Prior to expiry of specified period
71 Cessation of representative Form 8 (a) Immediately after 6-month period; (b) Immediately after 1 month of cessation; (c) Next business day after cessation
72 Change of representative's particulars Form 16 Within 14 days of change
73 Addition of regulated activities for appointed rep Form 6 Prior to carrying out additional activity
74 Addition of capital markets products type for appointed rep Form 6 Prior to dealing in additional type

Previous Next

Back to MAS Notices